Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China

by Shukui Qin, Eliza Kruger, Seng Chuen Tan, Shuqun Cheng, Nanya Wang, Jun Liang
Published 2018-08-01

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.

by Deborah M Anderson, Veena R Kumar, Diana L Arper, Eliza Kruger, S Pinar Bilir, Jason S Richardson
Published 2019-01-01

Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan

by Chun-Yi Lu, Ching-Hu Chung, Li-Min Huang, Eliza Kruger, Seng-Chuen Tan, Xu-Hao Zhang, Nan-Chang Chiu
Published 2020-08-01

Correction to: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan

by Chun-Yi Lu, Ching-Hu Chung, Li-Min Huang, Eliza Kruger, Seng-Chuen Tan, Xu-Hao Zhang, Nan-Chang Chiu
Published 2021-05-01